Enhanced immunogenicity of a genetic chimeric protein consisting of two virulence antigens of Streptococcus mutans and protection against infection.
about
Alterations in immunodominance of Streptococcus mutans AgI/II: lessons learned from immunomodulatory antibodiesCharacterization of the Streptococcus mutans P1 epitope recognized by immunomodulatory monoclonal antibody 6-11A.Beneficial immunomodulation by Streptococcus mutans anti-P1 monoclonal antibodies is Fc independent and correlates with increased exposure of a relevant target epitopeImmunological and protective effects of diepitopic subunit dental caries vaccinesA new small molecule specifically inhibits the cariogenic bacterium Streptococcus mutans in multispecies biofilms.Roles of salivary components in Streptococcus mutans colonization in a new animal model using NOD/SCID.e2f1-/- miceA therapeutic anti-Streptococcus mutans monoclonal antibody used in human passive protection trials influences the adaptive immune responseNovel epitopic region of glucosyltransferase B from Streptococcus mutans.Contribution of a Streptococcus mutans antigen expressed by a Salmonella vector vaccine in dendritic cell activationInduction of neutralizing antibodies in mice immunized with an amino-terminal polypeptide of Streptococcus mutans P1 protein produced by a recombinant Bacillus subtilis strain.Role of B7 costimulatory molecules in immune responses and T-helper cell differentiation in response to recombinant HagB from Porphyromonas gingivalisBactericidal antibody responses induced by meningococcal recombinant chimeric factor H-binding protein vaccines.Establishment of an animal model using recombinant NOD.B10.D2 mice to study initial adhesion of oral streptococci.Redirecting the humoral immune response against Streptococcus mutans antigen P1 with monoclonal antibodies.Good Manufacturing Practices production and analysis of a DNA vaccine against dental caries.Salivary IgA enhancement strategy for development of a nasal-spray anti-caries mucosal vaccine.Construction of a new fusion anti-caries DNA vaccine.Self-assembling anticaries mucosal vaccine containing ferritin cage nanostructure and glucan-binding region of S. mutans glucosyltransferase effectively prevents caries formation in rodents.Contribution of the alanine-rich region of Streptococcus mutans P1 to antigenicity, surface expression, and interaction with the proline-rich repeat domain.Comparison of immunological and microbiological characteristics in children and the elderly with or without dental caries.Comparing the cariogenic species Streptococcus sobrinus and S. mutans on whole genome level.Flagellin-PAc fusion protein is a high-efficacy anti-caries mucosal vaccine.Role of gene E2f1 in susceptibility to bacterial adherence of oral streptococci to tooth surfaces in mice.The role of anti-PAc (361-386) peptide SIgA antibody in professional oral hygiene of the elderly.Construction and immunogenic characterization of a fusion anti-caries DNA vaccine against PAc and glucosyltransferase I of Streptococcus mutans.
P2860
Q30355763-9460493B-3112-49E1-B9CA-E68E02BF8C48Q31098317-5CD9E5D6-4017-47E0-843A-DCCCA0EEF18AQ33607518-79A721AF-4814-49CC-850D-C1E0EC01A599Q33769018-A0FD5419-02AF-4791-8F5D-2D67008FD44AQ33845698-395BE98C-8F71-40BB-B243-E048ACC7483BQ34171629-25E83916-1892-4284-B15F-33F6E6AFB830Q35165024-A8A74B5F-101A-467A-8244-8090A6A98605Q35191183-C5D47E16-842E-40ED-9FC5-6E6579E440D2Q35191847-F6FFF707-3A17-440C-B784-1B30F31BB50AQ35206440-B993F839-DA80-45AF-B3E1-5278C263B475Q35549480-1507BC9D-3A90-4F4F-BA74-50E6A766B264Q36710765-8C2203DC-6AF0-475E-A6DC-A1411EB6F4B4Q37014929-CB18F774-C781-485E-B7DD-55FF30B329C2Q37623979-8C5C33DB-CBD8-4860-B4FF-3A9F94383E2DQ37729294-AA9D0C18-C814-4F30-8ED6-DC0F31872657Q38103192-7E4B28B9-2A69-4886-893A-4E5016950CF4Q38353517-8882B13F-F17E-466E-A8D1-4D2239EAF53FQ40113235-52B483FE-D2ED-433C-ABFB-8BE2F28A37E6Q41195302-25072E0B-6433-4316-82E8-E78F7BA920A6Q41471587-F2F4D271-0E90-4ECF-B49D-12CC28229BA0Q41617865-C01E7724-DDDC-451A-9F74-B49E69F90B63Q43954962-634BE72A-DD65-4F9B-B6D2-C4B5428EC2B3Q44946532-7255B3A7-B05E-41E7-8B4C-732C83290025Q45170357-BD695D21-FD11-48A7-9E48-B3F073CF539AQ51022076-69A50C31-372B-4F49-A288-12DC2F4B155F
P2860
Enhanced immunogenicity of a genetic chimeric protein consisting of two virulence antigens of Streptococcus mutans and protection against infection.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Enhanced immunogenicity of a g ...... protection against infection.
@ast
Enhanced immunogenicity of a g ...... protection against infection.
@en
Enhanced immunogenicity of a g ...... protection against infection.
@nl
type
label
Enhanced immunogenicity of a g ...... protection against infection.
@ast
Enhanced immunogenicity of a g ...... protection against infection.
@en
Enhanced immunogenicity of a g ...... protection against infection.
@nl
prefLabel
Enhanced immunogenicity of a g ...... protection against infection.
@ast
Enhanced immunogenicity of a g ...... protection against infection.
@en
Enhanced immunogenicity of a g ...... protection against infection.
@nl
P2093
P2860
P1476
Enhanced immunogenicity of a g ...... protection against infection.
@en
P2093
Christina Jespersgaard
George Hajishengallis
Jannet Katz
Leticia Lamberty-Mallory
Ping Zhang
Suzanne M Michalek
P2860
P304
P356
10.1128/IAI.70.12.6779-6787.2002
P407
P577
2002-12-01T00:00:00Z